{"id":"https://openalex.org/W7204279482","doi":"https://doi.org/10.1055/a-2929-2068","title":"An Efficient Synthesis of a 1,3-Dioxolan-4-one-Based Impurity of Allisartan Isoproxil","display_name":"An Efficient Synthesis of a 1,3-Dioxolan-4-one-Based Impurity of Allisartan Isoproxil","publication_year":2026,"publication_date":"2026-08-26","ids":{"openalex":"https://openalex.org/W7204279482","doi":"https://doi.org/10.1055/a-2929-2068"},"language":"en","primary_location":{"id":"doi:10.1055/a-2929-2068","doi":"https://doi.org/10.1055/a-2929-2068","is_oa":true,"landing_page_url":"https://doi.org/10.1055/a-2929-2068","pdf_url":null,"source":{"id":"https://openalex.org/S4210180892","display_name":"Pharmaceutical Fronts","issn_l":"2628-5088","issn":["2628-5088","2628-5096"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310321135","host_organization_name":"Georg Thieme Verlag","host_organization_lineage":["https://openalex.org/P4310321135","https://openalex.org/P4310320000"],"host_organization_lineage_names":["Georg Thieme Verlag","Thieme Medical Publishers (Germany)"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Fronts","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.1055/a-2929-2068","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5116464453","display_name":"Zhihao Du","orcid":"https://orcid.org/0009-0007-5125-8473","observed_orcids":["https://orcid.org/0009-0007-5125-8473"]},"institutions":[{"id":"https://openalex.org/I4210164195","display_name":"Shanghai Institute of Pharmaceutical Industry","ror":"https://ror.org/05mqm5297","country_code":"CN","type":"facility","lineage":["https://openalex.org/I4210164195"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhihao Du","raw_affiliation_strings":["Incubation Center for Science and Technology Achievements, China State Institute of Pharmaceutical Industry Co., Ltd., Shanghai, People's Republic of China","National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Incubation Center for Science and Technology Achievements, China State Institute of Pharmaceutical Industry Co., Ltd., Shanghai, People's Republic of China","institution_ids":["https://openalex.org/I4210164195"]},{"raw_affiliation_string":"National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai, People's Republic of China","institution_ids":["https://openalex.org/I4210164195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148283417","display_name":"Xin Gao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164195","display_name":"Shanghai Institute of Pharmaceutical Industry","ror":"https://ror.org/05mqm5297","country_code":"CN","type":"facility","lineage":["https://openalex.org/I4210164195"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xin Gao","raw_affiliation_strings":["Incubation Center for Science and Technology Achievements, China State Institute of Pharmaceutical Industry Co., Ltd., Shanghai, People's Republic of China","National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Incubation Center for Science and Technology Achievements, China State Institute of Pharmaceutical Industry Co., Ltd., Shanghai, People's Republic of China","institution_ids":["https://openalex.org/I4210164195"]},{"raw_affiliation_string":"National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai, People's Republic of China","institution_ids":["https://openalex.org/I4210164195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053974811","display_name":"Tengyu Zhang","orcid":"https://orcid.org/0009-0007-5929-3310","observed_orcids":["https://orcid.org/0009-0007-5929-3310","https://orcid.org/0000-0001-6886-2131"]},"institutions":[{"id":"https://openalex.org/I4210164195","display_name":"Shanghai Institute of Pharmaceutical Industry","ror":"https://ror.org/05mqm5297","country_code":"CN","type":"facility","lineage":["https://openalex.org/I4210164195"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Tengyu Zhang","raw_affiliation_strings":["Incubation Center for Science and Technology Achievements, China State Institute of Pharmaceutical Industry Co., Ltd., Shanghai, People's Republic of China","National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Incubation Center for Science and Technology Achievements, China State Institute of Pharmaceutical Industry Co., Ltd., Shanghai, People's Republic of China","institution_ids":["https://openalex.org/I4210164195"]},{"raw_affiliation_string":"National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai, People's Republic of China","institution_ids":["https://openalex.org/I4210164195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056943703","display_name":"Dongsheng Chen","orcid":"https://orcid.org/0000-0002-2135-8381","observed_orcids":["https://orcid.org/0000-0002-2135-8381"]},"institutions":[{"id":"https://openalex.org/I4210164195","display_name":"Shanghai Institute of Pharmaceutical Industry","ror":"https://ror.org/05mqm5297","country_code":"CN","type":"facility","lineage":["https://openalex.org/I4210164195"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Dongsheng Chen","raw_affiliation_strings":["Incubation Center for Science and Technology Achievements, China State Institute of Pharmaceutical Industry Co., Ltd., Shanghai, People's Republic of China","National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Incubation Center for Science and Technology Achievements, China State Institute of Pharmaceutical Industry Co., Ltd., Shanghai, People's Republic of China","institution_ids":["https://openalex.org/I4210164195"]},{"raw_affiliation_string":"National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai, People's Republic of China","institution_ids":["https://openalex.org/I4210164195"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5148370128","display_name":"Yu Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164195","display_name":"Shanghai Institute of Pharmaceutical Industry","ror":"https://ror.org/05mqm5297","country_code":"CN","type":"facility","lineage":["https://openalex.org/I4210164195"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yu Liu","raw_affiliation_strings":["Incubation Center for Science and Technology Achievements, China State Institute of Pharmaceutical Industry Co., Ltd., Shanghai, People's Republic of China","National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Incubation Center for Science and Technology Achievements, China State Institute of Pharmaceutical Industry Co., Ltd., Shanghai, People's Republic of China","institution_ids":["https://openalex.org/I4210164195"]},{"raw_affiliation_string":"National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd., Shanghai, People's Republic of China","institution_ids":["https://openalex.org/I4210164195"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210164195"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.63236059,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"08","issue":"03","first_page":"e230","last_page":"e238"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.5371000170707703,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.5371000170707703,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14459","display_name":"Synthesis and Reactions of Organic Compounds","score":0.10949999839067459,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13649","display_name":"Advanced Synthetic Organic Chemistry","score":0.09380000084638596,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/1-3-dioxolan-4-ones","display_name":"1,3-dioxolan-4-ones","score":0.9419999718666077},{"id":"https://openalex.org/keywords/process-related-impurities","display_name":"process-related impurities","score":0.8790000081062317},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.7329999804496765},{"id":"https://openalex.org/keywords/lactone-synthesis","display_name":"lactone synthesis","score":0.7110000252723694},{"id":"https://openalex.org/keywords/reference-materials","display_name":"reference materials","score":0.6010000109672546},{"id":"https://openalex.org/keywords/quality-control","display_name":"quality control","score":0.7250000238418579}],"concepts":[{"id":"https://openalex.org/C71987851","wikidata":"https://www.wikidata.org/wiki/Q7216430","display_name":"Impurity","level":2,"score":0.7962999939918518},{"id":"https://openalex.org/C134121241","wikidata":"https://www.wikidata.org/wiki/Q899301","display_name":"Yield (engineering)","level":2,"score":0.7634000182151794},{"id":"https://openalex.org/C2780595602","wikidata":"https://www.wikidata.org/wiki/Q898436","display_name":"Decarboxylation","level":3,"score":0.589900016784668},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.5620999932289124},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.4999000132083893},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.48669999837875366},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.40689998865127563},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.3564999997615814},{"id":"https://openalex.org/C75079739","wikidata":"https://www.wikidata.org/wiki/Q1571801","display_name":"Intramolecular force","level":2,"score":0.33550000190734863},{"id":"https://openalex.org/C2991944050","wikidata":"https://www.wikidata.org/wiki/Q36534","display_name":"Reaction conditions","level":3,"score":0.3325999975204468},{"id":"https://openalex.org/C2776612806","wikidata":"https://www.wikidata.org/wiki/Q59078","display_name":"Lactone","level":2,"score":0.31949999928474426},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.25949999690055847}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1055/a-2929-2068","doi":"https://doi.org/10.1055/a-2929-2068","is_oa":true,"landing_page_url":"https://doi.org/10.1055/a-2929-2068","pdf_url":null,"source":{"id":"https://openalex.org/S4210180892","display_name":"Pharmaceutical Fronts","issn_l":"2628-5088","issn":["2628-5088","2628-5096"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310321135","host_organization_name":"Georg Thieme Verlag","host_organization_lineage":["https://openalex.org/P4310321135","https://openalex.org/P4310320000"],"host_organization_lineage_names":["Georg Thieme Verlag","Thieme Medical Publishers (Germany)"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Fronts","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:fb92d25da50f4689ab5308adf3f63df6","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/fb92d25da50f4689ab5308adf3f63df6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceutical Fronts, Vol 08, Iss 03, Pp e230-e238 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1055/a-2929-2068","doi":"https://doi.org/10.1055/a-2929-2068","is_oa":true,"landing_page_url":"https://doi.org/10.1055/a-2929-2068","pdf_url":null,"source":{"id":"https://openalex.org/S4210180892","display_name":"Pharmaceutical Fronts","issn_l":"2628-5088","issn":["2628-5088","2628-5096"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj"],"host_organization":"https://openalex.org/P4310321135","host_organization_name":"Georg Thieme Verlag","host_organization_lineage":["https://openalex.org/P4310321135","https://openalex.org/P4310320000"],"host_organization_lineage_names":["Georg Thieme Verlag","Thieme Medical Publishers (Germany)"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Fronts","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.504800021648407,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1790558141","https://openalex.org/W1970012021","https://openalex.org/W1978998472","https://openalex.org/W1992737191","https://openalex.org/W2018522840","https://openalex.org/W2028901584","https://openalex.org/W2038508711","https://openalex.org/W2039665384","https://openalex.org/W2074969294","https://openalex.org/W2116631824","https://openalex.org/W2130315628","https://openalex.org/W2159729565","https://openalex.org/W2161418811","https://openalex.org/W2167732511","https://openalex.org/W2315148510","https://openalex.org/W2921705331","https://openalex.org/W2995419467","https://openalex.org/W3023529892","https://openalex.org/W3145527833"],"related_works":[],"abstract_inverted_index":{"Abstract":[0],"Hypertension":[1],"is":[2,55,83],"closely":[3],"associated":[4],"with":[5,28,187],"aberrant":[6],"activation":[7],"of":[8,46,59,80,127,146,184,191,222],"the":[9,43,94,110,124,128,139,147,158,180],"renin\u2013angiotensin":[10],"system.":[11],"Allisartan":[12],"isoproxil,":[13],"a":[14,65,104,152,196,207],"prodrug":[15],"angiotensin":[16],"II":[17],"receptor":[18],"blocker,":[19],"exhibits":[20],"improved":[21,157],"pharmacokinetic":[22],"stability":[23],"and":[24,102,174,205,219],"medication":[25],"safety":[26],"compared":[27],"agents":[29],"that":[30],"rely":[31],"on":[32],"CYP450-mediated":[33],"metabolism.":[34],"However,":[35],"multiple":[36],"process-related":[37,67],"impurities":[38],"are":[39],"inevitably":[40],"generated":[41],"during":[42],"industrial":[44],"synthesis":[45],"allisartan":[47,223],"isoproxil.":[48,224],"Among":[49],"its":[50,60],"impurity":[51],"profile,":[52],"Impurity":[53,91,164,185],"V":[54,92,165,186],"particularly":[56],"noteworthy":[57],"because":[58],"unique":[61],"1,3-dioxolan-4-one":[62],"structure.":[63],"As":[64],"typical":[66],"impurity,":[68],"it":[69],"cannot":[70],"be":[71],"readily":[72],"accessed":[73],"through":[74,169],"simple":[75],"chemical":[76],"transformations.":[77],"The":[78],"aim":[79],"this":[81],"study":[82],"to":[84,90,109,162,200],"establish":[85],"an":[86,188,201],"efficient":[87,125],"synthetic":[88,107,198],"route":[89,108,178,199],"for":[93,211],"first":[95],"time.":[96],"Starting":[97],"from":[98,160],"N-benzylimidazole,":[99],"we":[100],"designed":[101],"developed":[103],"novel":[105],"13-step":[106],"target":[111],"product.":[112],"A":[113],"key":[114],"intramolecular":[115],"cyclization":[116],"catalyzed":[117],"by":[118],"I2":[119],"under":[120],"mild":[121],"conditions":[122],"enabled":[123,179],"construction":[126],"imidazo-fused":[129],"1,3-dioxolane":[130],"lactone":[131,203],"core":[132],"in":[133],"57%":[134],"yield":[135,159,190],"while":[136],"effectively":[137],"suppressing":[138],"undesired":[140],"decarboxylation":[141],"side":[142],"reaction.":[143],"Furthermore,":[144],"optimization":[145],"C5":[148],"chlorination":[149],"step":[150],"using":[151],"dimethyl":[153],"sulfoxide/NaHCO3/CHCl3":[154],"system":[155,204],"significantly":[156],"36":[161],"81%.":[163],"was":[166],"subsequently":[167],"obtained":[168],"sequential":[170],"multistep":[171],"oxidation,":[172],"alkylation,":[173],"deprotection":[175],"reactions.":[176],"This":[177,193],"10-g":[181],"scale":[182],"preparation":[183],"overall":[189],"3.6%.":[192],"work":[194],"provides":[195],"practical":[197],"unstable":[202],"delivers":[206],"reliable":[208],"reference":[209],"standard":[210],"analytical":[212],"method":[213],"development,":[214],"thereby":[215],"supporting":[216],"quality":[217],"control":[218],"regulatory":[220],"submission":[221]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2026-08-27T00:00:00"}